From: A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark
Genotype
Number of patients (percentage of the total population n = 180)
Patients with PAVM identified (percentage of genotype subgroup)
HHT1
89 (49%)
38 (42.7%)
HHT2
67 (37%)
12 (17.9%)
JP-HHT
15 (8%)
5 (33%)
Clinical HHT
9 (5%)
2 (22.5%)